Floatz logo

Methylene Blue

Vasoplegia

Institute of Liver and Biliary Sciences, IndiaSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Vasoplegia cohort.

Asset / SponsorPhaseRating
Giapreza
University of California, San Francisco
Phase 2/3B

Same molecule, other indications

Methylene Blue is also rated in:

Refractory ShockDormant
BB
Indicative ·
69 / 100
View asset →
cirrhosis of liverDormant
BB
Indicative ·
65 / 100
View asset →
stomatitisDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →